Giese J, Rasmussen S, Nielsen M D, Ibsen H
J Hypertens Suppl. 1983 Oct;1(1):31-6.
We present a brief survey of changes in vasoactive peptide systems during therapy with angiotensin converting enzyme inhibitors. Particular attention is paid to several methodological problems which are relevant to the clinical biochemistry and physiology of patients treated with this new type of drug.
我们简要综述了血管紧张素转换酶抑制剂治疗期间血管活性肽系统的变化。特别关注了与使用这类新型药物治疗的患者临床生物化学和生理学相关的几个方法学问题。